Kang, J., Farina, A., Park, J., Kim, S., Kim, J., Rizzo, N. et al. (2008) Down Syndrome biochemical markers and screening for preeclampsia at first and second trimester: Correlation with the week of onset and severity. Prenatal Diagnosis, 28, 704-709.

has been cited by the following article:

• TITLE: The relationship between second trimester alpha fetoprotein levels and adverse pregnancy outcome

  AUTHORS: Rebecca Allen, Shemoon Marleen, Luxmi Velauthar, Kevin Harrington, Joseph Aquilina

  KEYWORDS: AFP; Alpha Fetoprotein; Pre-Eclampsia; Small for Gestational Age; Still Birth; Placental Abruption

  JOURNAL NAME: Open Journal of Obstetrics and Gynecology, Vol.3 No.2, March 13, 2013

  ABSTRACT: Design: Retrospective analysis. Setting: East London Hospital. Subjects: 724 women who had maternal serum alphafetoprotein levels measured between 15 to 19 weeks gestation. Main outcome measure: The main outcome measures were defined as any case of preeclampsia, small-for-gestational age (SGA) birth- weight th centile, placental abruption, stillbirth or early neonatal death. Methods: Women with MSAFP > 2.0 Multiples of Median (MoM) were classified as screen positive. Results: 41 (5.7%) women developed preeclampsia. Women with MSAFP > 2.0 Multiples of the Median (MoM) were significantly more likely to develop preeclampsia (p th centile (p